PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PROSTATE CANCER

摘要

The invention relates to a pharmaceutical composition, comprising a compound with a negative regulatory effect on the expression of protein BCAR-1, together with at least one acceptable pharmaceutical vehicle. Said pharmaceutical composition is particularly of use for the treatment of prostate cancers even when the above have become resistant to treatment by anti-androgenic compounds. The invention further relates to methods for detection and assessment of the malignancy of a prostate cancer in vitro.